Innovacell Inc.TSE: 504A

Announcement Regarding the Execution of a Product Commercialization Agreement with EVERSANA Life Science Services, LLC for the U.S. Market

Jul 23, 2026 at 7:30 AM UTC · Issued by Innovacell Inc. via TDnet

Innovacell Inc. (504A) Press Release

View Attachment

Earlier from Innovacell

Announcement Regarding Completion of FDA IND Review and Approval to Include U.S. Sites and Patients in the ICEF15 Multi-Regional Phase III TrialJul 2

All Innovacell news releases